Cargando…
Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation
BACKGROUND: Juvenile amyotrophic lateral sclerosis (JALS) is a rare form of motor neuron disease and occurs before 25 years of age. Only a few cases of juvenile-onset ALS have been reported. MATERIAL/METHODS: To study genetic and clinicopathological features in Chinese patients with juvenile ALS, we...
Autores principales: | Yu, Xiaolong, Zhao, Zhe, Shen, Hongrui, Bing, Qi, Li, Nan, Hu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289031/ https://www.ncbi.nlm.nih.gov/pubmed/30507891 http://dx.doi.org/10.12659/MSM.913724 |
Ejemplares similares
-
Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations
por: Wang, Peishan, et al.
Publicado: (2023) -
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis
por: Grassano, Maurizio, et al.
Publicado: (2022) -
De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia
por: Leblond, Claire S., et al.
Publicado: (2016) -
Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models
por: Parakh, S., et al.
Publicado: (2021) -
Diverse roles of FUS in Amyotrophic Lateral Sclerosis
por: Carri, Maria Teresa, et al.
Publicado: (2015)